Comutation of PIK3CA and TP53 in Residual Disease After Preoperative Anti-HER2 Therapy in ERBB2 (HER2)-Amplified Early Breast Cancer
Holmes, Frankie Ann, Levin, Maren K., Cao, Ying, Balasubramanian, Sohail, Ross, Jeffrey S., Krekow, Lea, McIntyre, Kristi, Osborne, Cynthia, Espina, Virginia, Liotta, Lance, O’Shaughnessy, JoyceJournal:
JCO Precision Oncology
DOI:
10.1200/po.18.00292
Date:
November, 2019
File:
PDF, 823 KB
2019
File converter
More search results
More benefits 
